BeyondSpring (BYSI) Competitors $1.70 +0.06 (+3.66%) As of 11:04 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BYSI vs. CABA, AVTE, VTYX, PRQR, OGI, RENB, TLSA, AVIR, IMRX, and JMACShould you be buying BeyondSpring stock or one of its competitors? The main competitors of BeyondSpring include Cabaletta Bio (CABA), Aerovate Therapeutics (AVTE), Ventyx Biosciences (VTYX), ProQR Therapeutics (PRQR), Organigram Global (OGI), Lunai Bioworks (RENB), Tiziana Life Sciences (TLSA), Atea Pharmaceuticals (AVIR), Immuneering (IMRX), and Maxpro Capital Acquisition (JMAC). These companies are all part of the "pharmaceutical products" industry. BeyondSpring vs. Its Competitors Cabaletta Bio Aerovate Therapeutics Ventyx Biosciences ProQR Therapeutics Organigram Global Lunai Bioworks Tiziana Life Sciences Atea Pharmaceuticals Immuneering Maxpro Capital Acquisition Cabaletta Bio (NASDAQ:CABA) and BeyondSpring (NASDAQ:BYSI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, risk and valuation. Is CABA or BYSI more profitable? BeyondSpring's return on equity of 0.00% beat Cabaletta Bio's return on equity.Company Net Margins Return on Equity Return on Assets Cabaletta BioN/A -92.11% -74.08% BeyondSpring N/A N/A N/A Do insiders and institutionals have more ownership in CABA or BYSI? 40.3% of BeyondSpring shares are held by institutional investors. 11.3% of Cabaletta Bio shares are held by insiders. Comparatively, 29.3% of BeyondSpring shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, CABA or BYSI? Cabaletta Bio has a beta of 3.01, indicating that its stock price is 201% more volatile than the S&P 500. Comparatively, BeyondSpring has a beta of 0.24, indicating that its stock price is 76% less volatile than the S&P 500. Which has better earnings and valuation, CABA or BYSI? BeyondSpring has higher revenue and earnings than Cabaletta Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCabaletta BioN/AN/A-$115.86M-$2.71-1.04BeyondSpring$1.75M39.18-$11.12MN/AN/A Does the media favor CABA or BYSI? In the previous week, Cabaletta Bio had 13 more articles in the media than BeyondSpring. MarketBeat recorded 16 mentions for Cabaletta Bio and 3 mentions for BeyondSpring. BeyondSpring's average media sentiment score of 0.83 beat Cabaletta Bio's score of 0.49 indicating that BeyondSpring is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cabaletta Bio 1 Very Positive mention(s) 5 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral BeyondSpring 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend CABA or BYSI? Cabaletta Bio currently has a consensus target price of $13.44, suggesting a potential upside of 375.91%. Given Cabaletta Bio's stronger consensus rating and higher possible upside, research analysts clearly believe Cabaletta Bio is more favorable than BeyondSpring.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cabaletta Bio 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.82BeyondSpring 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryBeyondSpring beats Cabaletta Bio on 7 of the 13 factors compared between the two stocks. Get BeyondSpring News Delivered to You Automatically Sign up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BYSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BYSI vs. The Competition Export to ExcelMetricBeyondSpringMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$68.56M$3.39B$6.06B$10.57BDividend YieldN/A2.30%5.73%4.80%P/E RatioN/A22.7385.0727.47Price / Sales39.18268.36518.67200.70Price / CashN/A46.9537.5761.53Price / Book-4.5910.5412.336.87Net Income-$11.12M-$52.58M$3.32B$276.69M7 Day Performance-5.03%0.74%0.70%0.70%1 Month Performance-9.09%15.64%10.27%8.83%1 Year Performance-31.73%18.08%74.67%36.06% BeyondSpring Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BYSIBeyondSpringN/A$1.70+3.7%N/A-34.1%$68.56M$1.75M0.0080News CoverageCABACabaletta Bio2.9985 of 5 stars$2.89+16.1%$13.44+365.2%-32.0%$264.32MN/A-1.0750High Trading VolumeAVTEAerovate TherapeuticsN/A$9.09+0.1%N/A-87.9%$263.47MN/A-3.0420News CoverageGap DownHigh Trading VolumeVTYXVentyx Biosciences1.9259 of 5 stars$3.65-1.6%$7.50+105.5%+56.0%$260.28MN/A-2.1730PRQRProQR Therapeutics2.1452 of 5 stars$2.46+7.4%$8.00+225.2%+35.9%$258.82M$20.46M-5.35180OGIOrganigram Global1.1768 of 5 stars$1.90-1.0%N/A+7.3%$255.25M$117.47M38.01860RENBLunai Bioworks0.7084 of 5 stars$1.54+21.7%N/A-72.0%$250.24MN/A-2.0020Positive NewsGap DownTLSATiziana Life Sciences0.6949 of 5 stars$2.14+0.5%N/A+130.4%$250.06MN/A0.008AVIRAtea Pharmaceuticals1.8626 of 5 stars$3.14+1.0%$6.00+91.1%-11.0%$249.19MN/A-1.9570IMRXImmuneering3.8464 of 5 stars$5.96-2.9%$16.40+175.2%+198.0%$247.76M$320K-3.1560Positive NewsJMACMaxpro Capital AcquisitionN/A$18.43flatN/AN/A$247.52MN/A0.002,021 Related Companies and Tools Related Companies CABA Competitors AVTE Competitors VTYX Competitors PRQR Competitors OGI Competitors RENB Competitors TLSA Competitors AVIR Competitors IMRX Competitors JMAC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BYSI) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeyondSpring Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BeyondSpring With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
